Table of Contents
ISRN Vascular Medicine
Volume 2012 (2012), Article ID 678137, 11 pages
http://dx.doi.org/10.5402/2012/678137
Review Article

Intracoronary Imaging and Histopathology of Late Phase In-Stent Restenosis after Coronary Stent Implantation

1Division of Cardiology, Nagoya City East Medical Center, Nagoya, Aichi 464-8547, Japan
21-2-23 Wakamizu, Chikusa, Nagoya, Aichi 464-8547, Japan

Received 4 October 2012; Accepted 20 October 2012

Academic Editors: D. Guidolin and C.-C. Wu

Copyright © 2012 Shigenori Ito et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Choussat, C. Klersy, A. J. R. Black et al., “Long-term (> or = years) outcome after Palmaz-Schatz stent implantation,” American Journal of Cardiology, vol. 88, no. 1, pp. 10–16, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Kimura, K. Abe, S. Shizuta et al., “Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries,” Circulation, vol. 105, no. 25, pp. 2986–2991, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Hasegawa, H. Tamai, E. Kyo et al., “Histopathological findings of new in-stent lesions developed beyond five years,” Catheterization and Cardiovascular Interventions, vol. 68, no. 4, pp. 554–558, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Ito, T. Yoshida, and S. Suzuki, “A case of extended late-phase in-stent restenosis after implantation of a bare-metal stent: intravascular ultrasound, optical coherence tomography and immunohistochemical findings,” Journal of Invasive Cardiology, vol. 23, no. 4, pp. E86–E91, 2011. View at Google Scholar · View at Scopus
  5. N. Gonzalo, P. W. Serruys, T. Okamura et al., “Optical coherence tomography patterns of stent restenosis,” The American Heart Journal, vol. 158, no. 2, pp. 284–293, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Nakazawa, F. Otsuka, M. Nakano et al., “The pathology of neoatherosclerosis in human coronary implants: bare-metal and drug-eluting stents,” Journal of the American College of Cardiology, vol. 57, no. 11, pp. 1314–1322, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Inoue, K. Abe, K. Ando et al., “Pathological analyses of long-term intracoronary Palmaz-Schatz stenting: is its efficacy permanent?” Cardiovascular Pathology, vol. 13, no. 2, pp. 109–115, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Takano, M. Yamamoto, S. Inami et al., “Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents. Extended late-phase observation by intracoronary optical coherence tomography,” Journal of the American College of Cardiology, vol. 55, no. 1, pp. 26–32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Ito, K. Nakasuka, K. Miyata et al., “Ruptured plaque in a bare-metal stent 8 years after implantation-comparison of IVUS and OCT findings,” Journal of Cardiology Cases, vol. 5, no. 1, pp. e1–e3, 2012. View at Google Scholar
  10. M. Habara, M. Terashima, K. Nasu et al., “Difference of tissue characteristics between early and very late restenosis lesions after bare-metal stent implantation: an optical coherence tomography study,” Circulation, vol. 4, pp. 232–238, 2011. View at Publisher · View at Google Scholar
  11. J. Cosgrave, S. J. Corbett, G. Melzi et al., “Late restenosis following sirolimus-eluting stent implantation,” American Journal of Cardiology, vol. 100, no. 1, pp. 41–44, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Virmani, G. Guagliumi, A. Farb et al., “Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?” Circulation, vol. 109, no. 6, pp. 701–705, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. S. J. Kang, G. S. Mintz, T. Akasaka et al., “Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation,” Circulation, vol. 123, no. 25, pp. 2954–2963, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Ito, K. Nakasuka, K. Miyata et al., “Late in-stent restenosis after sirolimus-eluting stent implantation is related to thrmobus foramtion-insight from a case with IVUS, OCT, and histological findings,” Journal of Cardiology Cases, vol. 5, no. 2, pp. e83–e86, 2012. View at Google Scholar
  15. S. Ito, K. Nakasuka, K. Morimoto et al., “Angiographic and clinical characteristics of patients with acetylcholine-induced coronary vasospasm on follow-up coronary angiography following drug-eluting stent implantation,” Journal of Invasive Cardiology, vol. 23, no. 2, pp. 57–64, 2011. View at Google Scholar · View at Scopus
  16. J. W. Kim, H. S. Seo, J. H. Park et al., “A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent. Differential recovery of coronary endothelial dysfunction,” Journal of the American College of Cardiology, vol. 53, no. 18, pp. 1653–1659, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Sawada, T. Shinke, J. Shite et al., “Impact of cytochrome P450 2C19*2 polymorphism on intra-stent thrombus after drug-eluting stent implantation in Japanese patients receiving clopidogrel,” Circulation Journal, vol. 75, no. 1, pp. 99–105, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Fujii, M. Masutani, and M. Ohyanagi, “Contribution of organized thrombus to in-stent restenosis after sirolimus-eluting stent implantation: optical coherence tomography findings,” European Heart Journal, vol. 29, no. 11, p. 1385, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Takano, Y. Xie, D. Murakami et al., “Various optical coherence tomographic findings in restenotic lesions after sirolimus-eluting stent implantation,” International Journal of Cardiology, vol. 134, no. 2, pp. 263–265, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Nakano, F. Otsuka, and R. Virmani, “Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation,” Circulation, vol. 124, p. e955, 2011. View at Publisher · View at Google Scholar
  21. P. Burke, F. D. Kolodgie, A. Falb et al., “Healed plaque ruptures and sudden coronary death Evidence that subclinical rupture has a role in plaque progression,” Circulation, vol. 103, no. 7, pp. 934–940, 2001. View at Publisher · View at Google Scholar
  22. S. Miyazaki, Y. Hyasa, T. Takahashi et al., “In vivo optical coherence tomography of very late drug-eluting stent thrombosis compared with late in-stent restenosis,” Circulation Journal, vol. 76, no. 2, pp. 390–398, 2012. View at Google Scholar
  23. M. Joner, A. V. Finn, A. Farb et al., “Pathology of drug-eluting stents in humans. Delayed healing and late thrombotic risk,” Journal of the American College of Cardiology, vol. 48, no. 1, pp. 193–202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. H. G. Song, D. W. Park, Y. H. Kim et al., “Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation,” Journal of the American College of Cardiology, vol. 59, no. 12, pp. 1093–1100, 2012. View at Publisher · View at Google Scholar
  25. G. G. Stefanini, R. A. Byrne, P. W. Serruys et al., “Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the isar-test 3, isar-test 4, and leaders randomized trials,” European Heart Journal, vol. 33, no. 10, pp. 1214–1222, 2012. View at Publisher · View at Google Scholar
  26. Y. Onuma, T. Muramatsu, A. Kharlamov, and P. W. Serruys, “Freeing the vessel from metallic cage: what can we achieve with bioresorbable vascular scaffolds?” Cardiovascular Intervention and Therapeutics, vol. 27, no. 3, pp. 141–154, 2012. View at Publisher · View at Google Scholar
  27. S. Nishio, K. Kosuga, K. Igaki et al., “Long-term (>10 years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki-tamai stents,” Circulation, vol. 125, pp. 2343–2353, 2012. View at Publisher · View at Google Scholar
  28. R. Mehran, G. Dangas, A. S. Abizaid et al., “Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome,” Circulation, vol. 100, no. 18, pp. 1872–1878, 1999. View at Google Scholar · View at Scopus
  29. M. Unverdorben, C. Vallbracht, B. Cremers et al., “Paclitaxel-coated balloon catheter versus paclitaxel-Coated stent for the treatment of coronary in-stent restenosis,” Circulation, vol. 119, no. 23, pp. 2986–2994, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Maluenda, I. Ben-Dor, M. A. Gaglia Jr et al., “Clinical outcomes and treatment after drug-eluting stent failure: the absence of traditional risk factors for in-stent restenosis,” Circulation, vol. 5, no. 1, pp. 12–19, 2012. View at Google Scholar
  31. Y. G. Ko, J. S. Kim, B. K. Kim et al., “Efficacy of drug-eluting stents for treating in-stent restenosis of drug-eluting stents (from the korean des isr multicenter registry study [kiss]),” American Journal of Cardiology, vol. 109, no. 5, pp. 607–613, 2012. View at Publisher · View at Google Scholar
  32. H. Rittger, J. Brachmann, A. M. Sinha et al., “A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the pepcad-des study,” Journal of the American College of Cardiology, vol. 59, no. 15, pp. 1377–1382, 2012. View at Publisher · View at Google Scholar